The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.15TKRW
861.43M · vs all stocks (USD)
Updated Nov 8, 2026
Revenue (TTM)
91.82BKRW
68.76M · vs all stocks (USD)
Updated Nov 8, 2026
Profit Margin
-60.65%
vs Health Information Services peers
Updated Nov 8, 2026
Beta
0.8890x
vs all stocks
Updated Nov 8, 2026
52-Week Change
-24.12%
vs all stocks
Updated Nov 8, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Nov 8, 2026
Market Capitalization
1.15TKRW
861.43M · vs all stocks (USD)
Updated Nov 8, 2026
Enterprise Value
1.08TKRW
806.63M · vs all stocks (USD)
Updated Nov 8, 2026
Forward P/E
-15.72x
vs Health Information Services peers
Updated Nov 8, 2026
Price to Sales (TTM)
12.53x
vs Health Information Services peers
Updated Nov 8, 2026
Price to Book (MRQ)
3.38x
vs Health Information Services peers
Updated Nov 8, 2026
Enterprise to Revenue
11.73x
vs Health Information Services peers
Updated Nov 8, 2026
Enterprise to EBITDA
-18.12x
vs Health Information Services peers
Updated Nov 8, 2026
Gross Margin
100.00%
vs Health Information Services peers
Updated Nov 8, 2026
Profit Margin
-60.65%
vs Health Information Services peers
Updated Nov 8, 2026
Operating Margin
-70.44%
vs Health Information Services peers
Updated Nov 8, 2026
Return on Assets (TTM)
-9.15%
vs Health Information Services peers
Updated Nov 8, 2026
Return on Equity (TTM)
-23.52%
vs Health Information Services peers
Updated Nov 8, 2026
Revenue (TTM)
91.82BKRW
68.76M · vs all stocks (USD)
Updated Nov 8, 2026
Revenue per Share (TTM)
1.46KKRWUpdated Nov 8, 2026
Quarterly Revenue Growth
22.00%
vs Health Information Services peers
Updated Nov 8, 2026
Gross Profit (TTM)
91.82BKRW
68.76M · vs all stocks (USD)
Updated Nov 8, 2026
EBITDA (TTM)
-59.45BKRW
-44.52M · vs all stocks (USD)
Updated Nov 8, 2026
Net Income (TTM)
-55.69BKRW
-41.70M · vs all stocks (USD)
Updated Nov 8, 2026
Quarterly Earnings Growth (YoY)
22.04%
vs Health Information Services peers
Updated Nov 8, 2026
Operating Cash Flow (TTM)
-51.82BKRW
-38.80M · vs all stocks (USD)
Updated Nov 8, 2026
Levered Free Cash Flow (TTM)
-99.02BKRW
-74.15M · vs all stocks (USD)
Updated Nov 8, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Nov 8, 2026
Payout Ratio
0.00%
vs Health Information Services peers
Updated Nov 8, 2026
Revenue
83.13BKRWFY2025 · Dec 31, 2025
Gross Profit
83.13BKRWFY2025 · Dec 31, 2025
Operating Income
-83.12BKRW
-62.24M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-46.83BKRWFY2025 · Dec 31, 2025
Income Tax Expense
555.11MKRWFY2025 · Dec 31, 2025
Net Income
-47.39BKRWFY2025 · Dec 31, 2025
EBIT
-21.12BKRWFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-70.35BKRWFY2025 · Dec 31, 2025
Research & Development
41.74BKRWFY2025 · Dec 31, 2025
Selling, General & Administrative
25.67BKRWFY2025 · Dec 31, 2025
Other Operating Expenses
662.06MKRWFY2025 · Dec 31, 2025
Non-operating Interest Income
1.01BKRWFY2025 · Dec 31, 2025
Non-operating Interest Expense
25.71BKRWFY2025 · Dec 31, 2025
EPS (Basic)
-760.72KRWFY2025 · Dec 31, 2025
EPS (Diluted)
-1.32KKRWFY2025 · Dec 31, 2025
Basic Shares Outstanding
62.30MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
62.30MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-47.39BKRWFY2025 · Dec 31, 2025
Operating Cash Flow
-7.58BKRWFY2025 · Dec 31, 2025
Free Cash Flow
-8.16BKRWFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
14.11BKRWFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-47.39BKRWFY2025 · Dec 31, 2025
Stock-based Compensation
19.24BKRWFY2025 · Dec 31, 2025
Other Non-cash Items
23.81BKRWFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-5.07BKRWFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
1.83BKRWFY2025 · Dec 31, 2025
Capital Expenditures
-585.41MKRWFY2025 · Dec 31, 2025
Net Intangibles (CF)
-8.99BKRWFY2025 · Dec 31, 2025
Purchase of Investments
-8.62BKRWFY2025 · Dec 31, 2025
Sale of Investments
16.58BKRWFY2025 · Dec 31, 2025
Other Investing Activity
-788.92MKRWFY2025 · Dec 31, 2025
Net Investing Cash Flow
6.58BKRWFY2025 · Dec 31, 2025
Long-term Debt Payments
-12.00BKRWFY2025 · Dec 31, 2025
Net Short-term Debt Issuance
18.88BKRWFY2025 · Dec 31, 2025
Net Financing Cash Flow
10.14BKRWFY2025 · Dec 31, 2025
Shares Outstanding
74.38MSharesUpdated Nov 8, 2026
Float Shares
62.92MSharesUpdated Nov 8, 2026
% Held by Insiders
14.31%
vs all stocks
Updated Nov 8, 2026
% Held by Institutions
12.11%
vs all stocks
Updated Nov 8, 2026
Total Cash (MRQ)
182.14BKRW
136.39M · vs all stocks (USD)
Updated Nov 8, 2026
Total Cash per Share (MRQ)
2.45KKRWUpdated Nov 8, 2026
Total Debt (MRQ)
108.96BKRW
81.59M · vs all stocks (USD)
Updated Nov 8, 2026
Total Debt to Equity (MRQ)
0.3286x
vs Health Information Services peers
Updated Nov 8, 2026
Current Ratio (MRQ)
1.10x
vs Health Information Services peers
Updated Nov 8, 2026
Book Value per Share (MRQ)
4.57KKRWUpdated Nov 8, 2026
Total Assets
369.91BKRW
277.00M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
55.62BKRWFY2025 · Dec 31, 2025
Total Liabilities
232.48BKRWFY2025 · Dec 31, 2025
Total Non-current Assets
314.29BKRWFY2025 · Dec 31, 2025
Total Non-current Liabilities
20.27BKRWFY2025 · Dec 31, 2025
Total Current Liabilities
212.21BKRWFY2025 · Dec 31, 2025
Cash
152.16MKRWFY2025 · Dec 31, 2025
Cash Equivalents
13.96BKRWFY2025 · Dec 31, 2025
Cash & Cash Equivalents
14.11BKRWFY2025 · Dec 31, 2025
Other Short-term Investments
6.78BKRWFY2025 · Dec 31, 2025
Accounts Receivable
21.80BKRWFY2025 · Dec 31, 2025
Inventory
124.28MKRWFY2025 · Dec 31, 2025
Accounts Payable
6.18MKRWFY2025 · Dec 31, 2025
Short-term Debt
97.27BKRWFY2025 · Dec 31, 2025
Other Current Liabilities
-80.00KRWFY2025 · Dec 31, 2025
Long-term Debt
14.31BKRWFY2025 · Dec 31, 2025
Common Stock (Book)
14.63BKRWFY2025 · Dec 31, 2025
Retained Earnings
-426.11BKRWFY2025 · Dec 31, 2025
Total Shareholders' Equity
137.43BKRW
102.91M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
8.18KKRWUpdated Nov 8, 2026
52-Week High
24.55KKRWUpdated Nov 8, 2026
52-Week Change
-24.12%
vs all stocks
Updated Nov 8, 2026
Beta
0.8890x
vs all stocks
Updated Nov 8, 2026
50-Day MA
11.12KKRWUpdated Nov 8, 2026
200-Day MA
14.43KKRWUpdated Nov 8, 2026
Avg 10-Day Volume
3.27MSharesUpdated Nov 8, 2026
Avg 30-Day Volume
1.83MSharesUpdated Nov 8, 2026
Diluted EPS (TTM)
-1.32KKRWUpdated Nov 8, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
High R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Heavy R&D and stock pay, with the share count growing across six years.
Reads
Where is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 100%, higher than 95% of its Health Information Services peers (median 61.2%)Significant